Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

550 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Apixaban 5 mg Twice Daily and Clinical Outcomes in Patients With Atrial Fibrillation and Advanced Age, Low Body Weight, or High Creatinine: A Secondary Analysis of a Randomized Clinical Trial.
Alexander JH, Andersson U, Lopes RD, Hijazi Z, Hohnloser SH, Ezekowitz JA, Halvorsen S, Hanna M, Commerford P, Ruzyllo W, Huber K, Al-Khatib SM, Granger CB, Wallentin L; Apixaban for Reduction of Stroke and Other Thromboembolic Complications in Atrial Fibrillation (ARISTOTLE) Investigators. Alexander JH, et al. Among authors: hohnloser sh. JAMA Cardiol. 2016 Sep 1;1(6):673-81. doi: 10.1001/jamacardio.2016.1829. JAMA Cardiol. 2016. PMID: 27463942 Clinical Trial.
Pharmacological therapy of atrial fibrillation.
Grönefeld G, Bender B, Li YG, Hohnloser SH. Grönefeld G, et al. Among authors: hohnloser sh. Thorac Cardiovasc Surg. 1999 Aug;47 Suppl 3:334-8. doi: 10.1055/s-2007-1013194. Thorac Cardiovasc Surg. 1999. PMID: 10520763 Review.
Adenosine-induced atrial fibrillation.
Israel C, Klingenheben T, Grönefeld G, Hohnloser SH. Israel C, et al. Among authors: hohnloser sh. J Cardiovasc Electrophysiol. 2000 Jul;11(7):825. doi: 10.1111/j.1540-8167.2000.tb00057.x. J Cardiovasc Electrophysiol. 2000. PMID: 10921803 No abstract available.
Beta-blocker therapy in atrial fibrillation.
Grönefeld GC, Hohnloser SH. Grönefeld GC, et al. Among authors: hohnloser sh. Pacing Clin Electrophysiol. 2003 Jul;26(7 Pt 2):1607-12. doi: 10.1046/j.1460-9592.2003.t01-1-00239.x. Pacing Clin Electrophysiol. 2003. PMID: 12914610 Review.
Rationale and design of ACTIVE: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events.
Active Steering Committee; ACTIVE Investigators; Connolly S, Yusuf S, Budaj A, Camm J, Chrolavicius S, Commerford PJ, Flather M, Fox KA, Hart R, Hohnloser S, Joyner C, Pfeffer M, Anand I, Arthur H, Avezum A, Bethala-Sithya M, Blumenthal M, Ceremuzynski L, De Caterina R, Diaz R, Flaker G, Frangin G, Franzosi MG, Gaudin C, Golitsyn S, Goldhaber S, Granger C, Halon D, Hermosillo A, Hunt D, Jansky P, Karatzas N, Keltai M, Lanas F, Lau CP, Le Heuzey JY, Lewis BS, Morais J, Morillo C, Oto A, Paolasso E, Peters RJ, Pfisterer M, Piegas L, Pipillis T, Proste C, Sitkei E, Swedberg K, Synhorst D, Talajic M, Trégou V, Valentin V, van Mieghem W, Weintraub W, Varigos J. Active Steering Committee, et al. Am Heart J. 2006 Jun;151(6):1187-93. doi: 10.1016/j.ahj.2005.06.026. Am Heart J. 2006. PMID: 16781218 Clinical Trial.
Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy.
Hohnloser SH, Pajitnev D, Pogue J, Healey JS, Pfeffer MA, Yusuf S, Connolly SJ; ACTIVE W Investigators. Hohnloser SH, et al. J Am Coll Cardiol. 2007 Nov 27;50(22):2156-61. doi: 10.1016/j.jacc.2007.07.076. Epub 2007 Nov 13. J Am Coll Cardiol. 2007. PMID: 18036454 Free article. Clinical Trial.
550 results